Literature DB >> 22049214

Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.

Jamie C Zampell1, Sonia Elhadad, Tomer Avraham, Evan Weitman, Seth Aschen, Alan Yan, Babak J Mehrara.   

Abstract

Mechanisms regulating lymphedema pathogenesis remain unknown. Recently, we have shown that lymphatic fluid stasis increases endogenous danger signal expression, and these molecules influence lymphatic repair (Zampbell JC, et al. Am J Physiol Cell Physiol 300: C1107-C1121, 2011). Endogenous danger signals activate Toll-like receptors (TLR) 2, 4, and 9 and induce homeostatic or harmful responses, depending on physiological context. The purpose of this study was to determine the role of TLRs in regulating tissue responses to lymphatic fluid stasis. A surgical model of lymphedema was used in which wild-type or TLR2, 4, or 9 knockout (KO) mice underwent tail lymphatic excision. Six weeks postoperatively, TLR KOs demonstrated markedly increased tail edema compared with wild-type animals (50-200% increase; P < 0.01), and this effect was most pronounced in TLR4 KOs (P < 0.01). TLR deficiency resulted in decreased interstitial and lymphatic transport, abnormal lymphatic architecture, and fewer capillary lymphatics (40-50% decrease; P < 0.001). Lymphedematous tissues of TLR KOs demonstrated increased leukocyte infiltration (P < 0.001 for TLR4 KOs), including higher numbers of infiltrating CD3+ cells (P < 0.05, TLR4 and TLR9 KO), yet decreased infiltrating F4/80+ macrophages (P < 0.05, all groups). Furthermore, analysis of isolated macrophages revealed twofold reductions in VEGF-C (P < 0.01) and LYVE-1 (P < 0.05) mRNA from TLR2-deficient animals. Finally, TLR deficiency was associated with increased collagen type I deposition and increased transforming growth factor-β1 expression (P < 0.01, TLR4 and TLR9 KO), contributing to dermal fibrosis. In conclusion, TLR deficiency worsens tissue responses to lymphatic fluid stasis and is associated with decreased lymphangiogenesis, increased fibrosis, and reduced macrophage infiltration. These findings suggest a role for innate immune responses, including TLR signaling, in lymphatic repair and lymphedema pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22049214      PMCID: PMC3287358          DOI: 10.1152/ajpcell.00284.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  56 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 2.  Alarmins: chemotactic activators of immune responses.

Authors:  Joost J Oppenheim; De Yang
Journal:  Curr Opin Immunol       Date:  2005-08       Impact factor: 7.486

3.  Lymphedema.

Authors:  Stanley G Rockson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-04

4.  High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis.

Authors:  Qing Lin; Xiao Ping Yang; Dan Fang; Xiangrong Ren; Hongyan Zhou; Jiazhu Fang; Xialin Liu; Shiyou Zhou; Feng Wen; Xiaohong Yao; Ji Ming Wang; Shao Bo Su
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-03       Impact factor: 8.311

5.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

Review 6.  Toll-like receptors, wound healing, and carcinogenesis.

Authors:  Johannes Kluwe; Ali Mencin; Robert F Schwabe
Journal:  J Mol Med (Berl)       Date:  2008-12-17       Impact factor: 4.599

Review 7.  Early events in the recognition of danger signals after tissue injury.

Authors:  David J Kaczorowski; Kevin P Mollen; Rebecca Edmonds; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2007-11-21       Impact factor: 4.962

Review 8.  High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.

Authors:  David S Pisetsky; Helena Erlandsson-Harris; Ulf Andersson
Journal:  Arthritis Res Ther       Date:  2008-06-30       Impact factor: 5.156

Review 9.  High mobility group box 1 protein, a cue for stem cell recruitment.

Authors:  Roberta Palumbo; Marco E Bianchi
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

10.  Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis.

Authors:  George Plitas; Bryan M Burt; Hoang M Nguyen; Zubin M Bamboat; Ronald P DeMatteo
Journal:  J Exp Med       Date:  2008-05-12       Impact factor: 14.307

View more
  32 in total

1.  Regulation of inflammation and fibrosis by macrophages in lymphedema.

Authors:  Swapna Ghanta; Daniel A Cuzzone; Jeremy S Torrisi; Nicholas J Albano; Walter J Joseph; Ira L Savetsky; Jason C Gardenier; David Chang; Jamie C Zampell; Babak J Mehrara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

Review 2.  Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors.

Authors:  Sophia Ran; Andrew Wilber
Journal:  J Leukoc Biol       Date:  2017-04-13       Impact factor: 4.962

3.  TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection.

Authors:  Ismael P Sauter; Katerine G Madrid; Josiane B de Assis; Anderson Sá-Nunes; Ana C Torrecilhas; Daniela I Staquicini; Renata Pasqualini; Wadih Arap; Mauro Cortez
Journal:  JCI Insight       Date:  2019-05-16

Review 4.  Bridging the divide between pathogenesis and detection in lymphedema.

Authors:  J Brandon Dixon; Michael J Weiler
Journal:  Semin Cell Dev Biol       Date:  2014-12-26       Impact factor: 7.727

Review 5.  Emerging trends in the pathophysiology of lymphatic contractile function.

Authors:  Sanjukta Chakraborty; Michael J Davis; Mariappan Muthuchamy
Journal:  Semin Cell Dev Biol       Date:  2015-01-21       Impact factor: 7.727

6.  Minimally invasive method for determining the effective lymphatic pumping pressure in rats using near-infrared imaging.

Authors:  Tyler S Nelson; Ryan E Akin; Michael J Weiler; Timothy Kassis; Jeffrey A Kornuta; J Brandon Dixon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-15       Impact factor: 3.619

Review 7.  New and Emerging Treatments for Lymphedema.

Authors:  Mark V Schaverien; Melissa B Aldrich
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

8.  A chronic and latent lymphatic insufficiency follows recovery from acute lymphedema in the rat foreleg.

Authors:  Uziel Mendez; Emily M Stroup; Laura L Lynch; Anna B Waller; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-31       Impact factor: 4.733

Review 9.  Lymphatic Dysfunction, Leukotrienes, and Lymphedema.

Authors:  Xinguo Jiang; Mark R Nicolls; Wen Tian; Stanley G Rockson
Journal:  Annu Rev Physiol       Date:  2017-10-13       Impact factor: 19.318

10.  Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.

Authors:  Tomer Avraham; Jamie C Zampell; Alan Yan; Sonia Elhadad; Evan S Weitman; Stanley G Rockson; Jacqueline Bromberg; Babak J Mehrara
Journal:  FASEB J       Date:  2012-11-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.